journal article·2019-07Open access

Analysis of early cellular responses of anterior cruciate ligament fibroblasts seeded on different molecular weight polycaprolactone films functionalized by a bioactive poly(sodium styrene sulfonate) polymer

Amélie Leroux, Jagadeesh K. Venkatesan, David G. Castner, Magali Cucchiarini, Véronique Migonney

Biointerphases· Volume 14· Issue 4

Abstract

With the growing number of anterior cruciate ligament (ACL) ruptures and the increased interest for regenerative medicine procedures, many studies are now concentrated on developing bioactive and biodegradable synthetic ligaments. For this application, the choice of raw materials with appropriate physicochemical characteristics and long-term degradation features is essential. Polycaprolactone (PCL) has the advantage of slow degradation that depends on its molecular weight. This study evaluates two PCL materials: a technical grade (PC60: 60 kDa) versus a medical grade (PC12: 80 kDa), both before and after functionalization with poly(sodium styrene sulfonate) (pNaSS). After determining the grafting process had little to no effect on the PCL physicochemical properties, sheep ACL fibroblast responses were investigated. The PC12 films induced a significantly lower expression of the tumor necrosis factor alpha inflammatory gene compared to the PC60 films. Both film types induced an overproduction of fibroblast growth factor-2 and transforming growth factor beta compared to the controls on day 5 and demonstrated collagen gene expression profiles similar to the controls on day 7. Upon protein adsorption, pNaSS grafting caused a rapid cell adhesion in the first 30 min and an increased adhesion strength (1.5-fold higher). Moreover, after 7 days, an increase in cell density and actin network development were noted on the grafted films.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Knee injuries and reconstruction techniques · Polymer Surface Interaction Studies · Total Knee Arthroplasty Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Biomaterials and Polymers of Specialty, Institut Galilée, Université Paris 13, Sorbonne Paris Cité, UMR CNRS 7244, 93430 Villetaneuse, France

Center of Experimental Orthopaedics, Saarland, University Medical Center and Saarland University, D-66421 Homburg/Saar, Germany

National ESCA and Surface Analysis Center for Biomedical Problems (NESAC/Bio), Department of Bioengineering and Department of Chemical Engineering, University of Washington, Box 351653, Seattle, Washington 98195

Funding

BPI · NIH · Deutsche Forschungsgemeinschaft

References (50)

Show source-provided references
1. 10.1302/2046-3758.32.200024110.1302/2046-3758.32.2000241 ↗
2. 10.1016/j.otsr.2010.09.00410.1016/j.otsr.2010.09.004 ↗
3. 10.1177/036354650426592610.1177/0363546504265926 ↗
4. 10.1177/0363546500028001290110.1177/03635465000280012901 ↗
5. 10.1016/j.biomaterials.2004.11.05010.1016/j.biomaterials.2004.11.050 ↗
6. 10.1016/S0142-9612(02)00156-410.1016/S0142-9612(02)00156-4 ↗
7. 10.1016/j.biomaterials.2005.05.07310.1016/j.biomaterials.2005.05.073 ↗
8. 10.1016/j.jbiomech.2006.09.02510.1016/j.jbiomech.2006.09.025 ↗
9. 10.1073/pnas.060883710410.1073/pnas.0608837104 ↗
10. 10.1016/j.jbiomech.2009.07.01910.1016/j.jbiomech.2009.07.019 ↗
11. 10.1016/j.progpolymsci.2010.04.00210.1016/j.progpolymsci.2010.04.002 ↗
12. 10.1016/j.actbio.2012.07.00810.1016/j.actbio.2012.07.008 ↗
13. 10.1007/s10529-013-1447-410.1007/s10529-013-1447-4 ↗
14. Chen J. · J. Biomed. Mater. Res. A · 2003 · 67 · 55910.1002/jbm.a.10120 ↗
15. 10.1016/j.addr.2015.03.00410.1016/j.addr.2015.03.004 ↗
16. 10.1002/jbm.82027050910.1002/jbm.820270509 ↗
17. 10.1016/S0142-9612(97)00145-210.1016/S0142-9612(97)00145-2 ↗
18. 10.1021/bm015563x10.1021/bm015563x ↗
19. 10.1021/bm070344i10.1021/bm070344i ↗
20. Lessim S. · Biomed. Mater. Eng. · 2013 · 4 · 289
21. 10.1016/j.biomaterials.2013.05.05810.1016/j.biomaterials.2013.05.058 ↗
22. 10.1016/j.irbm.2013.09.00610.1016/j.irbm.2013.09.006 ↗
23. 10.1016/j.irbm.2016.03.00610.1016/j.irbm.2016.03.006 ↗
24. 10.1016/j.actbio.2015.09.03010.1016/j.actbio.2015.09.030 ↗
25. 10.1021/la501862f10.1021/la501862f ↗
26. 10.1007/s11706-012-0154-810.1007/s11706-012-0154-8 ↗
27. 10.1002/jbm.a.3424710.1002/jbm.a.34247 ↗
28. 10.1002/jor.110015010410.1002/jor.1100150104 ↗
29. 10.1002/jor.110001030510.1002/jor.1100010305 ↗
30. 10.1515/pjct-2017-001710.1515/pjct-2017-0017 ↗
31. 10.1016/S0142-9612(02)00370-810.1016/S0142-9612(02)00370-8 ↗
32. 10.1016/j.polymdegradstab.2010.09.00710.1016/j.polymdegradstab.2010.09.007 ↗
33. 10.1021/bm050694+10.1021/bm050694+ ↗
34. 10.1016/j.joca.2016.10.01410.1016/j.joca.2016.10.014 ↗
35. Korzyńska A. · Biocybern. Biomed. Eng. · 2008 · 28 · 75 (
36. 10.1016/j.jcis.2016.12.02310.1016/j.jcis.2016.12.023 ↗
37. 10.1007/s10856-015-5539-710.1007/s10856-015-5539-7 ↗
38. 10.1016/j.jconrel.2011.09.06410.1016/j.jconrel.2011.09.064 ↗
39. 10.1002/app.3394710.1002/app.33947 ↗
40. 10.1016/j.ejpb.2015.02.00110.1016/j.ejpb.2015.02.001 ↗
41. 10.1016/S0142-9612(03)00535-010.1016/S0142-9612(03)00535-0 ↗
42. 10.1371/journal.pone.020572210.1371/journal.pone.0205722 ↗
43. 10.1016/S0142-9612(00)00274-X10.1016/S0142-9612(00)00274-X ↗
44. 10.1016/j.actbio.2015.12.00310.1016/j.actbio.2015.12.003 ↗
45. 10.1016/j.msec.2016.12.10710.1016/j.msec.2016.12.107 ↗
46. 10.1080/09205063.2015.103099110.1080/09205063.2015.1030991 ↗
47. 10.1002/jbm.a.3282810.1002/jbm.a.32828 ↗
48. 10.1016/j.actbio.2017.01.06610.1016/j.actbio.2017.01.066 ↗
49. 10.1109/IEMBS.2007.435349110.1109/IEMBS.2007.4353491 ↗
50. 10.1016/0267-6605(92)90031-N10.1016/0267-6605(92)90031-N ↗